跳至主要内容
临床试验/CTRI/2020/10/028625
CTRI/2020/10/028625尚未招募3 期

Effect of Sankara Sweda, Virechana Karma and Basti Karma followed by Vaishwanara Churna in the management of Amavata w.s.r. to Rheumatoid arthritis: An Open Labelled Randomized Comparative Clinical Trial - SWEVIRBA

IPGT and RA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • (1) Patients of either sex with age between 18 and 60 years.
  • (2) Willing and able to participate in the study.
  • (3) Patient having signs & symptoms of Amavata w.s.r Rheumatoid arthritis with fulfilling Diagnostic criteria.
  • (4) Chronicity: less than 10 years.
  • (5) Patients with post-chikungunya Rheumatoid arthritis will be included if fulfilling ACR diagnostic criteria.
  • (6) Patient fit and willing for Virechana Karma and Basti Karma in respective group.

排除标准

  • (1) Patients having severe systemic diseases like cardiac disorders and Cancer.
  • (2) Patients below 18 years and above 60 years.
  • (3) Pregnant/lactating women.
  • (4) Chronicity: more than 10 years.
  • (5) Patient not fit for Virechana Karma or Basti Karma in respective group.
  • (6) Patients having Gouty arthritis.

研究者

发起方
IPGT and RA

相似试验